Primary hepatic lymphoma of mucosa-associated lymphoid tissue type: A case report with cytogenetic study

International Journal of Surgical Pathology

Volumn 16, Issue 3, 2008, Pages 301-307

  Koubaa Mahjoub, Wafa ^a   Chaumette Planckaert, Marie Therese ^a   Penas, Eva Maria Murga ^b   Dierlamm, Judith ^b   Leroy, Karen ^a,c,d   Delfau, Marie Helene ^a,c,d   Loriau, Jerome ^a   Gaulard, Philippe ^a,c,d   Delchier, Jean Charles ^a   Zafrani, Elie Serge ^a   Copie Bergman, Christiane ^a,c,d  

^a HENRI MONDOR HOSPITAL   (France)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c INSERM   (France)

^d FACULTÉ DE MÉDECINE   (France)

Author keywords

Genetic translocation; Liver neoplasm; Mucosa associated lymphoid tissue lymphoma

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; IMMUNOGLOBULIN HEAVY CHAIN; LEVOFLOXACIN; LYSINE ACETYLSALICYLATE; METRONIDAZOLE; OMEPRAZOLE; RIFABUTIN;

ADULT; ARTICLE; BUERGER DISEASE; CAMPYLOBACTER JEJUNI; CASE REPORT; CHROMOSOME TRANSLOCATION; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; GASTRECTOMY; GASTROSCOPY; GENE TRANSLOCATION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEPATIC LYMPHOMA; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR GENETICS; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH BIOPSY; STOMACH ULCER; TRISOMY; TRISOMY 18; TRISOMY 3;

CHROMOSOMES, HUMAN, PAIR 18; CHROMOSOMES, HUMAN, PAIR 3; DISEASE-FREE SURVIVAL; GENE REARRANGEMENT, B-LYMPHOCYTE, HEAVY CHAIN; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LIVER NEOPLASMS; LYMPHOMA, B-CELL, MARGINAL ZONE; MALE; MIDDLE AGED; TRISOMY;

EID: 45749144357     PISSN: 10668969     EISSN: None     Source Type: Journal    
DOI: 10.1177/1066896907312671     Document Type: Article

References (53)

1. Zafrani ES, Gaulard P. Primary lymphoma of the liver. Liver. 1993 ; 13: 57-61.
2. Page RD, Romaguera JE, Osborne B., et al. Primary hepatic lymphoma: favorable outcome after combination chemotherapy. Cancer. 2001 ; 92: 2023-2029.
3. Lei KI Primary non-Hodgkin's lymphoma of the liver. Leuk Lymphoma. 1998 ; 29: 293-299.
4. Noronha V., Shafi NQ, Obando JA, Kummar S. Primary non-Hodgkin's lymphoma of the liver. Crit Rev Oncol Hematol. 2005 ; 53: 199-207.
5. Hamilton SR, Aaltonen LA Pathology and Genetics of Tumours of the Digestive System. Lyon, France: IARC Press ; 2000.
6. Bronowicki JP, Bineau C., Feugier P., et al. Primary lymphoma of the liver: clinical-pathological features and relationship with HCV infection in French patients. Hepatology. 2003 ; 37: 781-787.
7. Isaacson PG, Banks PM, Best PV, McLure SP, Muller-Hermelink HK, Wyatt JI Primary low-grade hepatic B-cell lymphoma of mucosa-associated lymphoid tissue (MALT)-type. Am J Surg Pathol. 1995 ; 19: 571-575.
8. Ueda G., Oka K., Matsumoto T., et al. Primary hepatic marginal zone B-cell lymphoma with mantle cell lymphoma phenotype. Virchows Arch. 1996 ; 428: 311-314.
9. Maes M., Depardieu C., Dargent JL, et al. Primary low-grade B-cell lymphoma of MALT-type occurring in the liver: a study of two cases. J Hepatol. 1997 ; 27: 922-927.
10. Prabhu RM, Medeiros LJ, Kumar D., et al. Primary hepatic low-grade B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) associated with primary biliary cirrhosis. Mod Pathol. 1998 ; 11: 404-410.
11. Sato S., Masuda T., Oikawa H., et al. Primary hepatic lymphoma associated with primary biliary cirrhosis. Am J Gastroenterol. 1999 ; 94: 1669-1673.
12. Bouron D., Leger-Ravet MB, Gaulard P., Franco D., Capron F. Unusual hepatic tumor. Ann Pathol. 1999 ; 19: 547-548.
13. Kirk CM, Lewin D., Lazarchick J. Primary hepatic B-cell lymphoma of mucosa-associated lymphoid tissue. Arch Pathol Lab Med. 1999 ; 123: 716-719.
14. Ye MQ, Suriawinata A., Black C., Min AD, Strauchen J., Thung SN Primary hepatic marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type in a patient with primary biliary cirrhosis. Arch Pathol Lab Med. 2000 ; 124: 604-608.
15. Chen F., Ike O., Wada H., Hitomi S. Pulmonary mucosa-associated lymphoid tissue lymphoma 8 years after resection of the same type of lymphoma of the liver. Jpn J Thorac Cardiovasc Surg. 2000 ; 48: 233-235.
16. Murakami J., Fukushima N., Ueno H., Saito T., et al. Primary hepatic low-grade B-cell lymphoma of the mucosa-associated lymphoid tissue type: a case report and review of the literature. Int J Hematol. 2002 ; 75: 85-90.
17. Mizuno S., Isaji S., Tabata M., Uemoto S., Imai H., Shiraki K. Hepatic mucosa-associated lymphoid tissue (MALT) lymphoma associated with hepatitis C. J Hepatol. 2002 ; 37: 872-873.
18. Takeshima F., Kunisaki M., Aritomi T., Osabe M., et al. Hepatic mucosa-associated lymphoid tissue lymphoma and hepatocellular carcinoma in a patient with hepatitis B virus infection. J Clin Gastroenterol. 2004 ; 38: 823-826.
19. Ascoli V., Lo Coco F., Artini M., Levrero M., Martelli M., Negro F. Extranodal lymphomas associated with hepatitis C virus infection. Am J Clin Pathol. 1998 ; 109: 600-609.
20. Streubel B., Simonitsch-Klupp I., Mullauer L., et al. Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites. Leukemia. 2004 ; 18: 1722-1726.
21. Conconi A., Martinelli G., Thieblemont C., et al. Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood. 2003 ; 102: 2741-2745.
22. Raderer M., Traub T., Formanek M., et al. Somatostatinreceptor scintigraphy for staging and follow-up of patients with extraintestinal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT)-type. Br J Cancer. 2001 ; 85: 1462-1466.
23. Gockel HR, Heidemann J., Lugering A., et al. Stable remission after administration of rituximab in a patient with primary hepatic marginal zone B-cell lymphoma. Eur J Haematol. 2005 ; 74: 445-447.
24. Yago K., Shimada H., Itoh M., et al. Primary low-grade B-cell lymphoma of mucosa-associated lymphoid tissue (MALT)-type of the liver in a patient with hepatitis C virus infection. Leuk Lymphoma. 2002 ; 43: 1497-1500.
25. Raderer M., Streubel B., Woehrer S., et al. High relapse rate in patients with MALT lymphoma warrants lifelong follow-up. Clin Cancer Res. 2005 ; 11: 3349-3352.
26. Orrego M., Guo L., Reeder C., et al. Hepatic B-cell non-Hodgkin's lymphoma of MALT type in the liver explant of a patient with chronic hepatitis C infection. Liver Transpl. 2005 ; 11: 796-799.
27. Chatelain D., Maes C., Yzet T., et al. Primary hepatic lymphoma of MALT-type: a tumor that can simulate a liver metastasis. Ann Chir. 2006 ; 131: 121-124.
28. Hamada M., Tanaka Y., Kobayashi Y., Takeshita E., Joko K. A case of MALT lymphoma of the liver treated by RFA and Rituximab. Nippon Shokakibyo Gakkai Zasshi. 2006 ; 103: 655-660.
29. Chung YW, Sohn JH, Paik CH, et al. High-grade hepatic mucosa-associated lymphoid tissue (MALT) lymphoma probably transformed from the low-grade gastric MALT lymphoma. Korean J Intern Med. 2006 ; 21: 194-198.
30. Nart D., Ertan Y., Yilmaz F., Yuce G., Zeytunlu M., Kilic M. Primary hepatic marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type in a liver transplant patient with hepatitis B cirrhosis. Transplant Proc. 2005 ; 37: 4408-4412.
31. Shin SY, Kim JS, Lim JK, Hahn JS, Yang WI, Suh CO Longlasting remission of primary hepatic mucosa-associated lymphoid tissue (MALT) lymphoma achieved by radiotherapy alone. Korean J Intern Med. 2006 ; 21: 127-131.
32. Lechapt-Zalcman E., Challine D., Delfau-Larue MH, Haioun C., Desvaux D., Gaulard P. Association of primary pleural effusion lymphoma of T-cell origin and human herpesvirus 8 in a human immunodeficiency virusseronegative man. Arch Pathol Lab Med. 2001 ; 125: 1246-1248.
33. Liu H., Ye H., Dogan A., et al. T(11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10. Blood. 2001 ; 98: 1182-1187.
34. Dierlamm J., Baens M., Stefanova-Ouzounova M., et al. Detection of t(11;18)(q21;q21) by interphase fluorescence in situ hybridization using API2 and MLT specific probes. Blood. 2000 ; 96: 2215-2218.
35. Murga Penas EM, Hinz K., Roser K., et al. Translocations t(11;18)(q21;q21) and t(14;18)(q32;q21) are the main chromosomal abnormalities involving MLT/MALT1 in MALT lymphomas. Leukemia. 2003 ; 17: 2225-2229.
36. Isaacson P., Wright DH Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer. 1983 ; 52: 1410-1416.
37. Isaacson PG Update on MALT lymphomas. Best Pract Res Clin Haematol. 2005 ; 18: 57-68.
38. Wotherspoon AC, Doglioni C., Diss TC, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet. 1993 ; 342: 575-577.
39. Cerroni L., Zochling N., Putz B., Kerl H. Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma. J Cutan Pathol. 1997 ; 24: 457-461.
40. de la Fouchardiere A., Vandenesch F., Berger F. Borrelia-associated primary cutaneous MALT lymphoma in a nonendemic region. Am J Surg Pathol. 2003 ; 27: 702-703.
41. Ferreri AJ, Guidoboni M., Ponzoni M., et al. Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. J Natl Cancer Inst. 2004 ; 96: 586-594.
42. Lecuit M., Abachin E., Martin A., et al. Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N Engl J Med. 2004 ; 350: 239-248.
43. Loddenkemper C., Longerich T., Hummel M., et al. Frequency and diagnostic patterns of lymphomas in liver biopsies with respect to the WHO classification. Virchows Arch. 2007 ; 450: 493-502.
44. Zafrani ES Aspects histologiques de l'hépatite C. In: Pawlotsky JM, Dhumeaux D, eds. Hepatite C. Paris, France: EDK ; 2004: 159-177.
45. Gisbert JP, Garcia-Buey L., Pajares JM, Moreno-Otero R. Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis. Gastroenterology. 2003 ; 125: 1723-1732.
46. Arcaini L., Paulli M., Boveri E., et al. Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles. Cancer. 2004 ; 100: 107-115.
47. Luppi M., Longo G., Ferrari MG, et al. Additional neoplasms and HCV infection in low-grade lymphoma of MALT type. Br J Haematol. 1996 ; 94: 373-375.
48. Tursi A., Brandimarte G., Torello M. Disappearance of gastric mucosa-associated lymphoid tissue in hepatitis C virus-positive patients after anti-hepatitis C virus therapy. J Clin Gastroenterol. 2004 ; 38: 360-363.
49. Olin JW Thromboangiitis obliterans (Buerger's disease). N Engl J Med. 2000 ; 343: 864-869.
50. Rocha M., Avenaud P., Menard A., et al. Association of Helicobacter species with hepatitis C cirrhosis with or without hepatocellular carcinoma. Gut. 2005 ; 54: 396-401.
51. Fukuda K., Kuroki T., Tajima Y., et al. Comparative analysis of Helicobacter DNAs and biliary pathology in patients with and without hepatobiliary cancer. Carcinogenesis. 2002 ; 23: 1927-1931.
52. Kuroki T., Fukuda K., Yamanouchi K., et al. Helicobacter pylori accelerates the biliary epithelial cell proliferation activity in hepatolithiasis. Hepatogastroenterology. 2002 ; 49: 648-651.
53. Streubel B., Vinatzer U., Lamprecht A., Raderer M., Chott A. T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma. Leukemia. 2005 ; 19: 652-658.